- System installed in over 80 hospitals and medical centers in the US,
Asia and Europe -
- More than half of the procedures were performed in the US -
CAESAREA, Israel -- (Business Wire)
Mazor Robotics Ltd. (TASE:MZOR; NASDAQ GM: MZOR), a developer of
innovative guidance systems and complementary products, announced today
that the 10,000th spinal surgery in which Mazor Robotics’
guidance system (Renaissance as well as the earlier Spine Assist) was
used has been completed successfully. The Renaissance Guidance System
was launched in mid 2012 and is being used by orthopedic and
neurosurgeons to perform a wide range of spine and brain surgeries.
“As we approach 50 Renaissance Guidance Systems in the US, our goal is
to accelerate the adoption of the system, to make it the standard of
care for spinal surgeons across the country,” said Ori Hadomi, CEO of
Mazor Robotics. “While we are very proud of the tools we have built for
the surgeons using Renaissance, what is most rewarding for the team at
Mazor is to see the way our system enables patients to quickly get back
on their feet and resume their daily activities, a reality that many
would have thought impossible only a few years ago.”
Renaissance improves the execution and results in a wide variety of
spine procedures, including minimally-invasive and percutaneous
degenerative repair, vertebrae stabilization and fixation for complex
spinal deformity as well as vertebral augmentation. To date, Renaissance
has been used in over 1,000 complex spinal deformity correction
procedures and thousands of minimally invasive procedures. Additionally,
Renaissance has been used in a variety of brain operations, including
Deep Brain Stimulation procedures.
There is a growing body of clinical data on the Renaissance Guidance
System with over 50 publications in major professional journals and
podium presentations at major international meetings, demonstrating the
superior performance over standard techniques. Demonstrating the
flexibility of the system, the youngest patient to be operated on using
Renaissance was five years old and the oldest patient was 92 years old.
By affording orthopedic and neurosurgeons the ability to create a
pre-operative blueprint of the ideal surgery for each patient in a
virtual 3D environment as well as providing them with a sophisticated
guidance system, Renaissance gives surgeons the peace of mind that they
can perform simple as well as complex procedures with predictable
results and potentially through a much less invasive approach.
“I have been incorporating Mazor Robotics technology into my practice
for over five years now,” said pediatric orthopedic surgeon Dr. Dennis
Devito of Children's Orthopedics of Atlanta (COA), GA. “I find it
provides improved patient care through enhancement of the surgeon’s
capabilities. As a surgeon that has many patients with severe spinal
deformity, the Renaissance Guidance System allows me to visualize and
plan my surgery so I can focus my attention on correcting my patients’
curve.”
Mazor anticipates its Renaissance Guidance System will be used in over
three thousand spine and brain procedures in 2015. As surgeons and
hospital administrators become more broadly aware of its benefits, the
Company expects this to significantly grow over the coming years as the
number of systems and surgeons using Renaissance increases.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through
innovation by developing and introducing revolutionary robotic-based
technology and products aimed at redefining the gold standard of quality
care. Mazor Robotics Renaissance® Guidance System enables surgeons to
conduct spine and brain procedures in a more accurate and secure manner.
For more information, please visit www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 and
other securities laws. Any statements in this release about future
expectations, plans or prospects for the Company, including without
limitation, statements regarding the acceleration of the adoption of the
Renaissance Guidance System to make it the standard of care for spinal
surgeons across the country, the benefits of the Renaissance, our
expectation that Renaissance will be used in over three thousand spine
and brain procedures in 2015 and that the number of such procedures will
significantly grow over the coming years, and other statements
containing the words “believes,” “anticipates,” “plans,” “expects,”
“will” and similar expressions are forward-looking statements. These
statements are only predictions based on Mazor's current expectations
and projections about future events. There are important factors that
could cause Mazor's actual results, level of activity, performance or
achievements to differ materially from the results, level of activity,
performance or achievements expressed or implied by the forward-looking
statements. Those factors include, but are not limited to, the impact of
general economic conditions, competitive products, product demand and
market acceptance risks, reliance on key strategic alliances,
fluctuations in operating results, and other factors indicated in
Mazor's filings with the Securities and Exchange Commission (SEC)
including those discussed under the heading "Risk Factors" in Mazor’s
annual report on Form 20-F filed with the SEC on April 9, 2014 and in
subsequent filings with the SEC. For more details, refer to Mazor's SEC
filings. Mazor undertakes no obligation to update forward-looking
statements to reflect subsequent occurring events or circumstances, or
to changes in our expectations, except as may be required by law.
Contacts:
Stephani Shipman, (407) 591-3461
Marketing Communications Manager
Mazor
Robotics, Inc.
s.shipman@mazorrobotics-us.com
or
Michael
Polyviou/Robert Jones – Investors
mpolyviou@evcgroup.com; bjones@evcgroup.com
212.850.6020;
646.201.5447
Source: Mazor Robotics
© 2024 Canjex Publishing Ltd. All rights reserved.